Science For Sale: How Drugmakers Captured The FDA
The pharmaceutical industry spent decades manipulating the country’s top drug regulator into rubber-stamping its products. The Trump administration is making matters worse.
The pharmaceutical industry spent decades manipulating the country’s top drug regulator into rubber-stamping its products. The Trump administration is making matters worse.
The move could vastly expand access to the blockbuster medications.
As millions of Americans face jaw-dropping health insurance premiums, major insurers are raking in profits and rewarding investors.
Soaring healthcare costs, cuts to community services, workforce shortages, and ping-ponging federal policy are all worsening a crisis in US health care.
The Danish drugmaker behind Ozempic topped Pfizer’s bid for Metsera, a move Pfizer describe as "reckless and unprecedented."
A Gallup survey found that the number of people using GLP-1 drugs has grown from 5.8% of the population in February 2024 to 12.4% today.
The drug intermediary overseeing the military’s TRICARE pharmacy program is limiting access to care and overcharging taxpayers hundreds of dollars on average per prescription.
The machines will run complex experiments to tackle problems ranging from nuclear power to cancer treatments.